Skip to Content

Join the 'Xarelto' group to help and get support from people like you.

Xarelto Blog

White Men May Get Better Treatment for Abnormal Heartbeat

Posted 6 days ago by Drugs.com

TUESDAY, June 30, 2015 – Women, Hispanics and blacks are less likely than white men to receive optimal treatment for atrial fibrillation in the United States, researchers say. The study of more than a half-million Medicare patients found that women with this abnormal heart rhythm are less likely than men to get blood thinners to prevent stroke, which is a serious risk with atrial fibrillation. Women, blacks and Hispanics are also less likely to get catheter ablation, a surgical procedure that can restore the heart's normal rhythm. "Across the board, women are offered less aggressive care, particularly in cardiology," said lead researcher Dr. Prashant Bhave, a clinical assistant professor of internal medicine at University of Iowa Health Care. "There are still gaps in how patients are treated," he said. "The most important one is the difference in prescribing blood thinners. Ablation ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Lovenox, Heparin, Prevention of Thromboembolism in Atrial Fibrillation, Eliquis, Rivaroxaban, Enoxaparin, Clexane, Fragmin, Arixtra, Thromboembolic Stroke Prophylaxis, Hep-Pak, Apixaban, Fondaparinux, Dalteparin, Dabigatran

Blood Thinners OK for Cancers That Spread to Brain, Study Finds

Posted 2 Jun 2015 by Drugs.com

TUESDAY, June 2, 2015 – Blood-thinning drugs are safe for treating blood clots in patients with cancer that has spread to the brain from other areas of the body, according to new research. Cancer normally increases a person's risk of blood clots, the study authors explained in a news release from the American Society of Hematology. When a cancer patient develops a clot, a blood thinner – also called an anticoagulant – is often added to the cancer treatment regimen to prevent the risk of blood clots traveling to the lungs. Such a clot can be fatal. However, if cancer spreads from other parts of the body to the brain (called brain metastases), doctors are hesitant to prescribe blood thinners because of concern they might cause bleeding in the head, which is already a risk for these patients, the study authors added. The new findings show that the use of blood thinners in these patients ... Read more

Related support groups: Cancer, Warfarin, Coumadin, Xarelto, Pradaxa, Lovenox, Heparin, Brain Tumor, Eliquis, Rivaroxaban, Enoxaparin, Clexane, Fragmin, Arixtra, Hep-Pak, Apixaban, Fondaparinux, Tinzaparin, Dabigatran, Dalteparin

Pharmacists Key to Whether Patients Take Blood Thinners

Posted 14 Apr 2015 by Drugs.com

TUESDAY, April 14, 2015 – Millions of older Americans are prescribed a blood thinner to help reduce the stroke risks associated with a dangerous irregular heart beat known as atrial fibrillation. A new study finds that even though a large percentage fail to take the potentially life-saving medications as prescribed, the intervention of their local pharmacist might help. In the study, a team led by Dr. Mintu Turakhia, an assistant professor of medicine at Stanford University, in Palo Alto, Calif., looked at the use of the blood thinner Pradaxa (dabigatran) by Veterans Administration outpatients who were prescribed the drug between 2010 and 2012. Pradaxa belongs to a new class of twice-daily oral blood thinners, and it is often prescribed for atrial fibrillation (nicknamed "a-fib"). "The new oral anticoagulants, such as dabigatran, represent the biggest medical change in the delivery of ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Prevention of Thromboembolism in Atrial Fibrillation, Eliquis, Rivaroxaban, Arixtra, Apixaban, Fondaparinux, Jantoven, Savaysa, Edoxaban, Arixtra 7.5 mg/dose, Dicumarol, Arixtra 5 mg/dose, Miradon, Anisindione, Arixtra 10 mg/dose

Blood Thinners Overprescribed for Low-Risk Irregular Heartbeat: Study

Posted 14 Apr 2015 by Drugs.com

TUESDAY, April 14, 2015 – As many as one-quarter of people with atrial fibrillation who have a low risk of stroke are given blood-thinning drugs they likely don't need, a new study contends . Atrial fibrillation – a common form of irregular heartbeat – can cause blood clots. Those blood clots can then travel to the brain and cause a stroke. To prevent this from happening, many people with atrial fibrillation are prescribed blood thinners. However, because the drugs also have a risk of causing excessive bleeding, they generally aren't recommended for people with atrial fibrillation who have the lowest risk for stroke, the study authors explained. The study included information from nearly 11,000 atrial fibrillation patients across the United States. They were all younger than 60. They were also all considered to have a low risk of stroke, according to the researchers. Still, the study ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Eliquis, Rivaroxaban, Arixtra, Apixaban, Fondaparinux, Jantoven, Edoxaban, Savaysa, Arixtra 7.5 mg/dose, Dicumarol, Arixtra 5 mg/dose, Miradon, Anisindione, Arixtra 10 mg/dose

Most Treatments for Blood Clots Appear Safe, Effective

Posted 16 Sep 2014 by Drugs.com

TUESDAY, Sept. 16, 2014 – Almost all the various treatment options for blood clots that form in veins are equally safe and effective, new research shows. In exploring the safety and effectiveness of treatments for such blood clots as deep vein thrombosis or pulmonary embolism (blood clot in a lung), Canadian researchers analyzed outcomes associated with eight blood-thinning options, including unfractionated heparin, low-molecular-weight heparin (LMWH) and fondaparinux in combination with vitamin K antagonists. The investigators also examined LMWH with dabigatran (Pradaxa), edoxaban, rivaroxaban (Xarelto), apixaban (Eliquis), as well as LMWH alone. After examining nearly 50 randomized studies, the researchers found that unfractionated heparin combined with vitamin K antagonist was associated with a higher percentage of recurrent blood clots over the course of three months than the ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pradaxa, Pulmonary Embolism, Heparin, Deep Vein Thrombosis, Eliquis, Rivaroxaban, Arixtra, Thrombotic/Thromboembolic Disorder, Apixaban, Hep-Pak, Fondaparinux, Dabigatran, Heparin Sodium, Venous Thromboembolism, Pulmonary Thromboembolism, Arixtra 7.5 mg/dose, Hep-Pak CVC, Arixtra 5 mg/dose

Study: Aspirin Might Work Instead of Warfarin for Deep Vein Clots

Posted 26 Aug 2014 by Drugs.com

TUESDAY, Aug. 26, 2014 – Aspirin may offer an alternative for people who've had blood clots in the deep veins of the legs and can't tolerate long-term use of blood thinners, according to Australian researchers. The condition, called deep vein thrombosis (DVT), can be life-threatening if clots break loose, travel to the lungs and block a pulmonary artery. Patients are usually prescribed blood thinners such as warfarin to prevent clot formation, the researchers noted. "Most people who have had a blood clot in a leg vein or an embolism where the clot blocks the blood flow have anticoagulant drug treatment, such as warfarin, for at least six months, first to dissolve the clot and then to prevent it happening again," said lead researcher Dr. John Simes, a professor of medicine at the University of Sydney. However, long-term use of warfarin (Coumadin) can be inconvenient, requiring frequent ... Read more

Related support groups: Aspirin, Warfarin, Coumadin, Xarelto, Deep Vein Thrombosis (DVT), Pradaxa, Deep Vein Thrombosis, Rivaroxaban, Ecotrin, Bayer Aspirin, Bufferin, Jantoven, Dabigatran, Low Dose ASA, Ascriptin, Aspergum, Buffered Aspirin, Ascriptin Enteric, Aspir-Low, Aspirin Low Strength

Pros, Cons to Dissolving Lung Clots: Study

Posted 17 Jun 2014 by Drugs.com

TUESDAY, June 17, 2014 – Drugs used to break up blood clots in the lungs may lower the risk of death, but they also increase the risk of bleeding, a new study finds. Researchers analyzed data from 16 trials involving use of clot-busting drugs called thrombolytics to treat life-threatening clots in the lungs (pulmonary embolism). Despite the drugs' apparent life-saving benefits, the risk of major bleeding, particularly in the brain, remains a concern, experts say. "The study advances our understanding, but is not enough to provide a definitive recommendation for use in all patients," said Dr. Joshua Beckman, director of the cardiovascular fellowship program at Brigham and Women's Hospital in Boston, who was not involved in the study. The evidence suggests that clot-busting therapy has merit but needs more study to refine the method by which it is given and to whom, added Beckman. What's ... Read more

Related support groups: Xarelto, Pradaxa, Pulmonary Embolism, Heparin, Rivaroxaban, Arixtra, Hep-Pak, Fondaparinux, Activase, Dabigatran, Streptokinase, Heparin Sodium, Urokinase, Cathflo Activase, Streptase, Alteplase, Kinlytic, Arixtra 5 mg/dose, Abbokinase, Hep-Pak CVC

Doctors' Groups Issue New Guidelines on Treating Common Irregular Heartbeat

Posted 28 Mar 2014 by Drugs.com

FRIDAY, March 28, 2014 – Reduced use of aspirin and the addition of three new blood thinners as treatment options are among the recommendations in updated guidelines to manage a heart rhythm disorder called atrial fibrillation, which is a major risk factor for stroke. According to the American Heart Association, atrial fibrillation involves rapid and disorganized electrical signals that cause the heart's two upper chambers – the atria – to contract rapidly and irregularly. Symptoms can include rapid and irregular heartbeat, heart palpitations, shortness of breath, dizziness, sweating, fatigue or chest pain. Atrial fibrillation is not a fatal condition, but it can increase a person's risk of stroke five-fold. That's because atrial fibrillation allows blood to pool in the atria and form clots, the AHA said. One study published in November at the AHA's annual meeting found that ... Read more

Related support groups: Aspirin, Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Prevention of Thromboembolism in Atrial Fibrillation, Eliquis, Rivaroxaban, Ecotrin, Bayer Aspirin, Apixaban, Bufferin, Jantoven, Dabigatran, Aspergum, Buffered Aspirin, Low Dose ASA, Easprin, ZORprin

Blood Thinners Now Recommended for People With Irregular Heartbeat

Posted 24 Feb 2014 by Drugs.com

MONDAY, Feb. 24, 2014 – People with an irregular heartbeat should take blood thinners to reduce their risk of stroke, an updated American Academy of Neurology (AAN) guideline recommends. Taking these drugs is especially important for people with irregular heartbeat who have already had a stroke or mini-stroke, experts say. Irregular heartbeat (atrial fibrillation) is a major risk factor for stroke because it causes blood to remain in the heart's upper chambers, according to the AAN. The blood can then form clots that can escape the heart and travel to the brain and cause a stroke. About 5 percent of people with untreated atrial fibrillation are likely to suffer a stroke within the next year, the neurology group pointed out. Blood thinners (anticoagulants) are highly effective in preventing strokes, but may cause bleeding and should be used only under close medical supervision, ... Read more

Related support groups: Xarelto, Pradaxa, Prevention of Thromboembolism in Atrial Fibrillation, Eliquis, Rivaroxaban, Apixaban, Dabigatran

Xarelto's Approval Expanded

Posted 5 Nov 2012 by Drugs.com

MONDAY, Nov. 5 – Approval of the anti-clotting drug Xarelto (rivaroxaban) has been expanded by the U.S. Food and Drug Administration to include treating deep vein thrombosis (DVT) or pulmonary embolism. DVT occurs when a blood clot forms in a vein deep in the body. If a clot breaks away and travels to an artery in the lungs, it becomes a potentially deadly condition called a pulmonary embolism. Xarelto was approved last year to treat clots stemming from knee or hip replacement and to lessen the risk of stroke in people with a form of abnormal heart rhythm called non-valvular atrial fibrillation. The drug's newest approvals were given based on clinical studies involving 9,478 people, the FDA said in a news release. As with other anti-clotting drugs, bleeding is the most common side effect. Xarelto is produced by Janssen Pharmaceuticals, based in Raritan, N.J. More information The FDA ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Deep Vein Thrombosis, Rivaroxaban

FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

Posted 2 Nov 2012 by Drugs.com

November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment. Blood clots occur when blood thickens and clumps together. DVT is a blood clot that forms in a vein deep in the body. Most deep vein blood clots occur in the lower leg or thigh. When a blood clot in a deep vein breaks off and travels to an artery in the lungs and blocks blood flow, it results in a potentially deadly condition called PE. Xarelto is already FDA-approved to reduce the risk of DVTs and PEs from occurring after knee or hip replacement surgery (July 2011), and to reduce the risk of stroke in people who have a type of abnormal heart rhythm called non-valvular atrial fibrillation (November 2011). The FDA reviewed ... Read more

Related support groups: Xarelto, Deep Vein Thrombosis (DVT), Pulmonary Embolism, Deep Vein Thrombosis, Deep Vein Thrombosis - First Event, Deep Vein Thrombosis - Recurrent Event, Rivaroxaban, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis Prophylaxis after Abdominal Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after General Surgery, Deep Vein Thrombosis Prophylaxis after Orthopedic Surgery

Irregular Heartbeat May Pose Higher Stroke Risk for Women Than Men

Posted 31 Aug 2012 by Drugs.com

FRIDAY, Aug. 31 – Women older than 75 who have a heart rhythm disorder called atrial fibrillation are 20 percent more likely to have a stroke than men in the same age group with atrial fibrillation, according to a large new study. However, researchers said the findings suggest that being a woman should not be included as an independent risk factor for stroke or blood clots, either in guidelines for treatment or risk assessment of patients with atrial fibrillation, because the difference doesn't hold for women younger than 75. The study included more than 87,000 atrial fibrillation patients in Denmark. Of those patients, more than 51 percent were female. After one year of follow-up, female patients younger than 75 did not have an increased risk of stroke, but those over age 75 had a 20 percent increased risk, the investigators found. The study was presented Sunday at the European ... Read more

Related support groups: Warfarin, Coumadin, Atrial Fibrillation, Xarelto, Pradaxa, Lovenox, Heparin, Prevention of Thromboembolism in Atrial Fibrillation, Rivaroxaban, Enoxaparin, Clexane, Fragmin, Arixtra, Hep-Pak, Fondaparinux, Tinzaparin, Dalteparin, Jantoven, Dabigatran, Normiflo

Quick-Reversal Method May Be at Hand for New Blood Thinner

Posted 20 Jun 2012 by Drugs.com

WEDNESDAY, June 20 – Newer blood-thinning drugs sometimes have one drawback: In cases where they trigger bleeding, their effects can be tough to reverse compared to the standard anticoagulant, warfarin. Now, a new study finds there are three different approaches to reverse the action of one new blood thinner, apixaban (Eliquis) – a drug that's currently under review by the U.S. Federal Drug Administration. Researchers in Spain noted that it remains unclear which method for reversing this new drug might be best. "If you have an accident or need emergency surgery, doctors have three ways to reverse [the older, standby blood-thinner] warfarin that work in a matter of minutes to hours. In contrast, there is little information on how best to reverse the effects of newer anticoagulants, which can take 10 to 18 hours," study author Dr. Gines Escolar, an associate professor of hematology at ... Read more

Related support groups: Warfarin, Coumadin, Xarelto, Rivaroxaban, Jantoven

FDA Panel Votes Against New Use for Blood Thinner Xarelto

Posted 24 May 2012 by Drugs.com

WEDNESDAY, May 23 – An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome. The panel of experts voted 6-to-4, with one member abstaining, against using the drug in these high-risk patients. Panel members said there wasn't enough data in company studies to definitively assess the medication's benefit at this time, the Associated Press reported. The decision came as something of a surprise, since FDA briefing documents filed Monday in advance of the panel meeting looked more favorably on the drug. A final decision from the FDA is expected June 29. The FDA is not required to follow the advice of its advisory panels, but it typically does. Xarelto (rivaroxaban) is one of a new class of blood thinners that has been developed to ... Read more

Related support groups: Xarelto, Rivaroxaban, Acute Coronary Syndrome

New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA

Posted 21 May 2012 by Drugs.com

MONDAY, May 21 – The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found. The review came in briefing documents that were filed Monday in advance of an FDA advisory panel meeting Wednesday, at which the panel is to vote on whether to recommend approval of Xarelto for treating people with acute coronary syndrome (a group of conditions brought on by sudden reduced blood flow to the heart). The FDA is not required to follow the advice of its expert panels, but the agency typically does. A final decision is expected by the end of June, according to the documents. Xarelto (rivaroxaban) is one of a new class of blood thinners that have been developed to overcome some of the problems that exist with the standard treatment, warfarin (Coumadin), which requires constant dose ... Read more

Related support groups: Atrial Fibrillation, Xarelto, Prevention of Thromboembolism in Atrial Fibrillation, Rivaroxaban, Acute Coronary Syndrome

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Atrial Fibrillation, Deep Vein Thrombosis (DVT), Deep Vein Thrombosis, Pulmonary Embolism, Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery, Deep Vein Thrombosis - Prophylaxis, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Prevention of Thromboembolism in Atrial Fibrillation, Deep Vein Thrombosis - Recurrent Event, Pulmonary Embolism - Recurrent Event

Xarelto Patient Information at Drugs.com